Capital World Investors 13D and 13G filings for NovoCure Limited:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 6:14 pm Sale |
2024-02-07 | 13G | NovoCure Limited NVCR |
Capital World Investors | 3,276,996 3.100% |
-2,557,084 (-43.83%) |
Filing |
| 2023-12-11 06:19 am Sale |
2023-12-11 | 13G | NovoCure Limited NVCR |
Capital World Investors | 5,834,080 5.500% |
-7,065,315 (-54.77%) |
Filing |
| 2023-02-13 2:49 pm Purchase |
2023-02-14 | 13G | NovoCure Limited NVCR |
Capital World Investors | 12,899,395 12.300% |
176,181 (+1.38%) |
Filing |
| 2022-02-11 2:48 pm Purchase |
2022-02-14 | 13G | NovoCure Limited NVCR |
Capital World Investors | 12,723,214 12.300% |
1,694,783 (+15.37%) |
Filing |
| 2021-05-10 12:49 pm Purchase |
2021-05-10 | 13G | NovoCure Limited NVCR |
Capital World Investors | 11,028,431 10.700% |
3,272,161 (+42.19%) |
Filing |
| 2021-02-16 12:14 pm Purchase |
2021-02-16 | 13G | NovoCure Limited NVCR |
Capital World Investors | 7,756,270 7.600% |
7,756,270 (New Position) |
Filing |